Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC). - Concepedia

Concepedia

Publication | Closed Access

Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC).

24

Citations

12

References

2012

Year

Jan Stoehlmacher-Williams, L. Obermann, Gerhard Ehninger, Eray Goekkurt

Abstract

The EGFR-R497K polymorphism is a potential predictor for overall survival in HNSCC patients treated with cetuximab based therapy in the palliative setting.

References

	Year	Citations

Page 1